Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial.Georg Pfeiler, Michael Gnant, Lidija Filipcic et al.|Journal of Clinical Oncology|2014Cited by 7